Covered recipient · General Payments record
KNARIK OGANESYAN
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Psychiatric/Mental Health
General Payments · PY2021–2024
$850.86
- Reported across 18 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $429.60 | 11 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $121.18 | 1 |
| Janssen Pharmaceuticals, Inc | $114.00 | 1 |
| Amgen Inc. | $46.72 | 2 |
| Lundbeck LLC | $33.60 | 2 |
| Organon LLC | $27.73 | 1 |
| Krystal Biotech Inc | $26.85 | 1 |
| GlaxoSmithKline, LLC. | $21.11 | 1 |
| Alkermes, Inc. | $19.37 | 1 |
| Lilly USA, LLC | $19.04 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (11)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Alkermes, Inc. | $19.37 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120565281 | CMS |
| Amgen Inc. | $17.76 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117342398 | CMS |
| Amgen Inc. | $28.96 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117644467 | CMS |
| GlaxoSmithKline, LLC. | $21.11 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116232397 | CMS |
| Janssen Pharmaceuticals, Inc | $114.00 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1077925139 | CMS |
| Krystal Biotech Inc | $26.85 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1084811876 | CMS |
| Lilly USA, LLC | $19.04 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135780258 | CMS |
| Lundbeck LLC | $16.11 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146069688 | CMS |
| Lundbeck LLC | $17.49 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146069690 | CMS |
| Novo Nordisk Inc | $121.18 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100430323 | CMS |
| Organon Llc | $27.73 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136221865 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.